Correlation Between Vaxcyte and United Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vaxcyte and United Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxcyte and United Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxcyte and United Therapeutics, you can compare the effects of market volatilities on Vaxcyte and United Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxcyte with a short position of United Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxcyte and United Therapeutics.
Diversification Opportunities for Vaxcyte and United Therapeutics
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Vaxcyte and United is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Vaxcyte and United Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on United Therapeutics and Vaxcyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxcyte are associated (or correlated) with United Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of United Therapeutics has no effect on the direction of Vaxcyte i.e., Vaxcyte and United Therapeutics go up and down completely randomly.
Pair Corralation between Vaxcyte and United Therapeutics
Given the investment horizon of 90 days Vaxcyte is expected to generate 1.03 times less return on investment than United Therapeutics. In addition to that, Vaxcyte is 1.93 times more volatile than United Therapeutics. It trades about 0.06 of its total potential returns per unit of risk. United Therapeutics is currently generating about 0.11 per unit of volatility. If you would invest 21,872 in United Therapeutics on November 9, 2024 and sell it today you would earn a total of 13,503 from holding United Therapeutics or generate 61.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vaxcyte vs. United Therapeutics
Performance |
| Timeline |
| Vaxcyte |
| United Therapeutics |
Vaxcyte and United Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaxcyte and United Therapeutics
The main advantage of trading using opposite Vaxcyte and United Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxcyte position performs unexpectedly, United Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United Therapeutics will offset losses from the drop in United Therapeutics' long position.| Vaxcyte vs. Larimar Therapeutics | Vaxcyte vs. Syndax Pharmaceuticals | Vaxcyte vs. Merus BV | Vaxcyte vs. Sutro Biopharma |
| United Therapeutics vs. Incyte | United Therapeutics vs. Alnylam Pharmaceuticals | United Therapeutics vs. Ultragenyx | United Therapeutics vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |